Clinical Trial Update: Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed [Phase 3]

View source ↗

Summary

Phase 3 trial of resiniferatoxin for knee osteoarthritis was withdrawn. No efficacy results reported in this document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Knee Pain
• Osteoarthritis of the Knee

Drugs mentioned

• Resiniferatoxin (resiniferatoxin)

Snippet

Sponsor: Sorrento Therapeutics, Inc. | Conditions: Osteoarthritis, Knee, Osteo Arthritis Knee | Phase 3 | Status: WITHDRAWN